Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand
- 20 April 2007
- Vol. 25 (16) , 3075-3079
- https://doi.org/10.1016/j.vaccine.2007.01.023
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Persisting Immune Responses Indicating Long-Term Protection after Booster Dose with Meningococcal Group B Outer Membrane Vesicle VaccineClinical and Vaccine Immunology, 2006
- Validation of the serum bactericidal assay for measurement of functional antibodies against group B meningococci associated with vaccine trialsVaccine, 2005
- New Zealand Epidemic of Meningococcal Disease Identified by a Strain with Phenotype B:4:P1.4The Journal of Infectious Diseases, 1998